Featured News
More News
SDRC researchers use zinc to target insulin producing cells
To treat diabetes directly, rather than manage its symptoms, doctors need a way to get drugs to cells that produce insulin. The key, Stanford researchers report, may be those cells’ affinity for zinc.
Antibody developed by Dr. Weissman and his colleagues shows promise in a small clinical trial as a safe cancer therapy
An immunotherapy conceived at Stanford appeared safe in an early clinical trial. Half of the participants responded positively to the treatment, aimed at triggering macrophages to engulf cancer cells, the researchers reported.
The ISPAD Clinical Practice consensus Guidelines 2018 are now available online
ISPAD’s Clinical Practice Consensus Guidelines are the only comprehensive set of clinical recommendations for children, adolescents, and young adults with diabetes worldwide!
Bruce Buckingham has won the ISPAD Prize for Innovation in Pediatric Diabetes Care for 2018
Dr. Buckingham is a Professor in the Department of Pediatric Endocrinology at Stanford Medical Center and Stanford Children’s Hospital.
Stanford GSB study identifies most effective way to steer schoolchildren away from sodas and other sweetened drinks toward drinking water instead.
What’s the best way to persuade children to drink water instead of unhealthy, sugar-laced beverages?
A decade-long study finds that roughly 1 in 10 people carry genetic variants that may blunt the blood sugar-lowering effects of widely used diabetes medications — raising new questions about precision medicine in diabetes care. Read more...